Physician profile
Daniel Frenkel
NPI 1144427832
$11,203.66
in general payments reported to CMS, 2019-2025
27 companies · $2,034 in 2025
The $2,034 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,610 · 2020: $1,347 · 2021: $1,930 · 2022: $754 · 2023: $972 · 2024: $558 · 2025: $2,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929 · Travel and Lodging: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,928.70 |
| Travel and Lodging | $634.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $6,602.18 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Biosense Webster, INC. | $1,287.51 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Abbott Laboratories | $856.54 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite |
| Boston Scientific Corporation | $729.17 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, S-Icd System Magnet |
| E.R. Squibb & Sons, L.L.C. | $258.55 | 2019-2020 | |
| Medtronic Vascular, INC. | $192.79 | 2019 | |
| Atricure, INC. | $175.99 | 2019-2023 | |
| Abiomed | $174.76 | 2019-2025 | Impella |
| Pfizer INC. | $148.83 | 2019-2020 | |
| Vektor Medical INC. | $105.13 | 2025 | Vmap |
| Cardiva Medical, INC. | $91.46 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Angiodynamics, INC. | $78.20 | 2025 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.25 | 2019-2020 | |
| Baxter Healthcare | $70.83 | 2024-2025 | Perclot, Hillrom - Carnation Ambulatory Monitor |
| Chiesi USA, INC. | $58.79 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $47.75 | 2019-2020 | |
| Irhythm Technologies, INC. | $41.10 | 2019-2020 | |
| Ethicon US, LLC | $38.34 | 2024 | Dermabond, Vistaseal, Stratafix |
| Akcea Therapeutics, INC. | $31.83 | 2019-2020 | |
| Getinge USA Sales, LLC | $24.49 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.40 | 2019 | |
| Preventice Services, LLC | $15.26 | 2019 | |
| Sensible Medical Innovations INC | $14.88 | 2019 | |
| Bardy Diagnostics, INC. | $12.78 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $10.83 | 2019 | |
| G Medical Diagnostic Services, INC. | $10.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Frenkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.